386
Suscriptores
+224 horas
+67 días
+1730 días
Distribuciones de tiempo de publicación
Carga de datos en curso...
Find out who reads your channel
This graph will show you who besides your subscribers reads your channel and learn about other sources of traffic.
Análisis de publicación
| Mensajes | Vistas | Acciones | Ver dinámicas |
01 Atlas of Clinical Endocrinology and Metabolism 2024 | 23 | 0 | Loading... |
02 Medical Algorithm For Diagnosis and Treatment | 10 | 0 | Loading... |
03 GHAI Essential Pediatrics 10th Ed. 2023 | 26 | 0 | Loading... |
04 GHAI Essential Pediatrics 10th Ed. 2023 | 24 | 0 | Loading... |
05 Pediatric Decision-Making Strategies 2nd ed 2016 | 11 | 0 | Loading... |
06 The Calgary Black Book 15th ed 2022 One of the best Medical algorithms books | 13 | 0 | Loading... |
07 DeGroot's Endocrinology-Basic Science and Clinical Practice 8th ed 2023 | 11 | 0 | Loading... |
08 Short Stature , Growth Hormone Therapy and Skeletal Dysplasias UpToDate 2020 | 9 | 0 | Loading... |
09 Pediatric ESAP Endocrine Self-Assessment Program 2021-2022 | 22 | 0 | Loading... |
10 National Immunization Schedule 2024 | 19 | 0 | Loading... |
11 DeGroot's Endocrinology-Basic Science and Clinical Practice 8th ed 2023 | 6 | 0 | Loading... |
12 Short Stature , Growth Hormone Therapy and Skeletal Dysplasias UpToDate 2020 | 14 | 0 | Loading... |
13 Pediatric Decision-Making Strategies 2nd ed 2016 | 9 | 0 | Loading... |
14 Pediatric ESAP Endocrine Self-Assessment Program 2021-2022 | 20 | 0 | Loading... |
15 The Calgary Black Book 15th ed 2022 One of the best Medical algorithms books | 10 | 0 | Loading... |
16 DeGroot's Endocrinology-Basic Science and Clinical Practice 8th ed 2023 | 19 | 0 | Loading... |
17 Medical Algorithm For Diagnosis and Treatment | 12 | 0 | Loading... |
18 Short stature Cases Not Take Growth Hormone Therapy :
1- Dysmorphic Syndromes associted with short stature
2- Skeletal Dysplasia
3- Systemic Diseases causing Growth Failure
4- Children under Corticosteroid Therapy
5- Famelial Short Stature
Males with a bone age 15.5 years or more
And females with a bone age 13.5 years or more
6- Children with known risk of malignancy e.g. chromosomal abnormality such as Down and Bloom Syndromes
7- Evidence of Brain atrophy
8- Growth failure due to diabetes
9- I.Q. less than 75% . | 16 | 0 | Loading... |
19 - هناك تداخل بين دواء Mebendazole و Metronidazole نعم و تم شرحها سابقاً ام بنسبه إعطاء دواء lbendazole مع دواء Metronidazole ليس هناك ويمكن للطبيب صرفهم معاً
الصيدلاني عبدالناصر عارف | 67 | 0 | Loading... |
20 استقبال الطوارئ والباطنه | 75 | 1 | Loading... |
21 https://t.me/Emergency_intensivecare
كلمة السر 2024 micromedex | 96 | 0 | Loading... |
22 https://t.me/Syndromes_1 | 75 | 0 | Loading... |
23 للأسف الشديد نسخة كتاب
Nelson Textbook of Pediatrics 22ed 2024
ناقصة 36 صفحة من صفحة 991 حتى صفحة 1028
Unfortunately, it is a book copy
Nelson Textbook of Pediatrics 22ed 2024
36 pages are missing from page 991 to page 1028 | 73 | 0 | Loading... |
24 GINA 2024 | 39 | 0 | Loading... |
25 Abstract of Endocrinology and Pediatrics Interplay in Clinical Practice 2023 | 61 | 0 | Loading... |
26 Media files | 32 | 0 | Loading... |
27 كلمات السر الجديدة لتطبيقات Micromedex الأمريكية الشهيرة في الادويه 2024: | 41 | 0 | Loading... |
28 Alagille Syndrome | 41 | 0 | Loading... |
29 Media files | 47 | 0 | Loading... |
30 Media files | 37 | 0 | Loading... |
31 Media files | 35 | 0 | Loading... |
32 Medical Syndromes 2022 | 67 | 0 | Loading... |
33 GINA 2024 | 49 | 0 | Loading... |
34 Potassium Chloride Dose | 61 | 0 | Loading... |
35 Media files | 46 | 0 | Loading... |
36 Media files | 31 | 0 | Loading... |
37 Pholcodine Anaphylaxis during general anaesthesia
Administration of pholcodine causes production of antibodies linked with fatalities during surgery, when essential neuromuscular blocking agents (NMBAs) are administered to prevent patient movement under general anaesthesia. These antibody levels gradually fall to low levels several years after last dose of pholcodine. However, the presence of these antibodies causes a 300-fold increase in risk of anaphylaxis during anaesthesia .
The link was suspected when neighbouring Norway and Sweden were found to have tenfold differences of surgical anaphylaxis deaths. Sweden had no products approved containing pholcodine, whereas 40% of the population in Norway had consumed the single approved pholcodine product. Norway withdrew pholcodine from the market in 2007, and the prevalence of anti-suxamethonium antibodies fell by over 80% in two years. A corresponding fall in anaesthesia deaths followed .
A similar disparity exists between NMBA anaphylaxis rates in Australia, where pholcodine consumption is high and the US, where pholcodine is banned. In the US, anaphylaxis rates are so low that some anaesthetists question the existence of such reactions to NMBAs. Conversely, Australian anaesthetists have requested a ban on pholcodine due to the high anaphylaxis rate in the country. However, the Therapeutic Goods Administration declined the request in January 2015, pending further reviews to follow. In February 2023, the Therapeutic Goods Administration reversed its previous decision and banned products containing pholcodine.
In contrast, the European Medicines Agency's 2012 "Assessment report for Pholcodine containing medicinal products" concludes this: The Committee considered that evidence of an association between pholcodine use and development of NMBA-related anaphylaxis is circumstantial, not entirely consistent and therefore does not support the conclusion that there is a significant risk of cross-sensitisation to NMBAs and subsequent development of anaphylaxis during surgery .
In September 2022, the European Medicines Agency (EMA) started reviewing its position at the request of the French ANSM, which withdrew all pholcodine-containing medicines after preliminary results from a local study showed an increased risk of anaphylaxis after pholcodine use . The EMA review concluded on 14 December 2022 with the recommendation that pholcodine be withdrawn from the EU market. This decision was ratified by the European Commission in March 2023. The UK government recalled all products containing pholcodine in March 2023.
Source : en.wikipedia.org
9/5/2024 | 50 | 0 | Loading... |
38 Duplex Ultrasound of Superficial Leg Veins /Erika Mendoza, Christopher R. Lattimer, Nick Morrison - @MedicalBooksStoreA- Springer (2014)
@MedicalBooksStoreA
@MedicalBooksStoress
@Medical_Books_Storess | 55 | 0 | Loading... |
39 💎Harvard 8th Annual Board Review and Update in Pulmonary, Sleep, and Critical Care Medicine 2023
✅Format : 27 MP4 files
⭐️File Size : 5.27 GB
⭐️Course content
⭐️The Best price
✈️Contact us: @DR_ATM
🟠The Best Store: @STORE_ATM | 72 | 0 | Loading... |
Repost from Naser's Medical Education
Atlas of Clinical Endocrinology and Metabolism 2024
Repost from Naser's Medical Education
Photo unavailableShow in Telegram
GHAI Essential Pediatrics 10th Ed. 2023
Repost from Naser's Medical Education
The Calgary Black Book 15th ed 2022 One of the best Medical algorithms books
Repost from Naser's Medical Education
DeGroot's Endocrinology-Basic Science and Clinical Practice 8th ed 2023
Repost from Naser's Medical Education
Short Stature , Growth Hormone Therapy and Skeletal Dysplasias UpToDate 2020
Repost from Naser's Medical Education
Photo unavailableShow in Telegram
Pediatric ESAP Endocrine Self-Assessment Program 2021-2022
Repost from Naser's Medical Education
Photo unavailableShow in Telegram
National Immunization Schedule 2024